iGenetic Diagnostics is a company based in Mumbai, Maharashtra, India, operating in the healthtech sector. Founded in 2013, it now employs 8 individuals. The company was established by Arunima Patel, ...
Funding stage:
Venture Round
Last funding:
27/02/2017
Total funding:
$20.49 Mn+
Revenue:
Investors
Employee count:
18
Last 90d
18
Last 90d
Glassdoor Rating:
iGenetic Diagnostics: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders5
Latest Filing Date30 March 2023- Funding Events28
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of iGenetic Diagnostics
As of 31 March 2023, iGenetic Diagnostics's equity is held by 5 shareholders, with the top three being Manipal Hospitals, MEGM CDC Global Diagnostic Venture Limited, and Arunima Patel.
Manipal Hospitals holds the largest stake in iGenetic Diagnostics at 43.0% as of 31 March 2023.
As of 31 March 2023, founders collectively hold 7.7% equity in iGenetic Diagnostics.
As of 31 March 2023, investors collectively hold 38.4% equity in iGenetic Diagnostics.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links